J. Reuter

发表

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer

R. Herrmann, C. Mamot, C. Rochlitz, 2003, British Journal of Cancer.

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

R. Herrmann, C. Rochlitz, J. Boulay, 2003, British Journal of Cancer.

Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells

R. Herrmann, C. Rochlitz, M. Mehtali, 1999, Cancer Immunology, Immunotherapy.

Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype

D. Huhn, R. Herrmann, C. Rochlitz, 1992, Cancer.

Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).

R. Herrmann, M. Fey, B. van Hille, 1997, European journal of haematology.

Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma.

F. Gudat, R. Herrmann, A. Lohri, 1997, Journal of clinical pathology.

Topoisomerase IIa mRNA and tumour cell proliferation in non-Hodgkin's lymphoma

F. Gudat, R. Herrmann, A. Lohri, 2022 .

MTS1 expression and prognosis in acute myeloid leukemia

R. Herrmann, C. Rochlitz, M. Fey, 1997, Annals of Hematology.

Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC.

R. Herrmann, B. van Hille, R. Herrmann, 1995, Clinical chemistry.

Folinic acid effect on 5-fluorouracil kinetics in vivo

R. Herrmann, R. Port, J. Reuter, 2004, Journal of Cancer Research and Clinical Oncology.

STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer.

R. Herrmann, C. Rochlitz, J. Boulay, 2004, Neoplasia.

Amplification of SKI is a prognostic marker in early colorectal cancer.

R. Herrmann, C. Rochlitz, J. Boulay, 2004, Neoplasia.

bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer.

R. Herrmann, C. Rochlitz, C. Thiede, 1998, European journal of cancer.

Five putative drug resistance parameters (MDR1/P‐glycoprotein, MDR‐associated protein, glutathione‐S‐transferase, bcl‐2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemias

R. Herrmann, M. Fey, A. Lohri, 1997 .

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

R. Herrmann, C. Rochlitz, A. Lowy, 2002, British Journal of Cancer.

Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumour cell lines.

R. Herrmann, B. van Hille, A. Lohri, 1996, Anticancer research.

DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer

R. Herrmann, C. Rochlitz, J. Boulay, 2002, International journal of cancer.

mRNA expression, measured by quantitative reverse transcriptase polymerase chain reaction, of five putative drug resistance parameters, in normal and leukaemic peripheral blood and bone marrow.

R. Herrmann, B. van Hille, A. Tichelli, 1997, Acta haematologica.